Josh Schafer

Outlook Adobe Marketing Cloud Remote AI

biotechnology: pharmaceutical preparations health care biotechnology research pharmaceutical manufacturing rare disease therapeutics drug development clinical trials patient advocacy therapeutic pipeline niemann-pick disease type c sleep disorders urea cycle disorders vascular ehlers-danlos syndrome patient first approach regulatory submissions arimoclomol miplyffa olpruva azstarys prodrug technology idiopathic hypersomnia cognitive dysfunction sodium phenylbutyrate therapeutic access life-changing therapies expedited approval pathways rare diseases biopharma partnerships commercialization specialists therapeutic candidates data-driven narratives orphan drug designation patient care clinical development fda approval therapeutic landscapes innovative drug development drug approval processes neurological disorders patient-centered research advanced therapeutics complex development challenges clinical severity scale pharmaceutical innovation therapeutic efficacy neurological manifestations patient demographics biopharmaceutical research environment for innovation collaborative development pharmaceutical partnerships data narratives therapeutic efficacy assessment unmet medical needs patient-centric approach genetic disorders lysosomal storage diseases fda-approved products clinical pipeline investigational therapies narcolepsy orphan drug development breakthrough therapy designations commercialization strategies disease awareness campaigns data-driven development healthcare providers adult patients rare disease market innovative solutions therapeutic development regulatory narratives patient needs healthcare sector biopharmaceutical industry competitive landscape health wellness & fitness pharmaceuticals medical hospital & health care